Recent developments include ClearOne's merger agreement with Cortigent, ongoing strategic transactions, financial challenges with wider losses and revenue declines, and risks related to Nasdaq listing compliance and financing.

• On July 2, 2026, ClearOne entered into a merger agreement with Cortigent, creating a Nasdaq-listed Cortigent Holdings entity, with Vivani Medical receiving 12.5 million shares of ClearOne common stock as consideration [N1].
• ClearOne's Q2 2025 financial results showed wider losses and revenue decline, accompanied by plans for asset sales and strategic alternatives [N4].
• The company has experienced stock price declines following wider quarterly losses and year-over-year revenue dips reported in Q1 and Q2 2025 [N8, N4].
• ClearOne is actively pursuing strategic alternatives including mergers, acquisitions, and financing to enhance stockholder value [N2].
• The company faces risks of Nasdaq delisting due to non-compliance with listing standards and has submitted compliance plans [S2].
• ClearOne's largest stockholder holds significant influence, including consent rights over new debt and material transactions, which may affect strategic decisions [S1, S11].

The merger with Cortigent and concurrent financing could provide ClearOne with a new operating business and capital base, potentially enhancing stockholder value. The strategic alternatives under evaluation may include acquisitions or investments that could reposition the company in growth markets. The company's ability to maintain public company compliance and manage legacy obligations while pursuing these alternatives demonstrates operational discipline during transition.

ClearOne faces substantial risks including continued net losses, limited liquidity, and the possibility of Nasdaq delisting due to non-compliance with listing standards. The success of the merger with Cortigent and related financing is uncertain and subject to multiple conditions. Failure to complete strategic transactions or obtain additional financing could force the company to curtail operations or wind down, resulting in reduced recoveries for stockholders. Dependence on a small management team and potential cybersecurity vulnerabilities add to operational risks.

ClearOne's prior competitive advantages in professional audio and video collaboration solutions have been relinquished following the sale of operating assets. The company's current position is transitional, focusing on warranty servicing and strategic alternatives rather than product innovation or market competition. The upcoming merger with Cortigent represents a potential shift in business focus, but ClearOne currently lacks a moat in its legacy operations due to the asset sale and reduced operational scope.

• Going Concern and Financing Risk: ClearOne has incurred significant losses and negative cash flows, with substantial doubt about its ability to continue as a going concern. Additional financing or successful strategic transactions are required to sustain operations.
• Nasdaq Listing Compliance Risk: The company is not in compliance with Nasdaq listing standards, including minimum stockholders' equity, and faces risk of delisting which could reduce liquidity and market price of its common stock.
• Strategic Transaction Execution Risk: Completion of the merger with Cortigent and related financing is subject to multiple conditions outside the company's control. Failure to complete these transactions could materially adversely affect the company's financial condition and operations.
• Operational and Personnel Risk: ClearOne operates with a significantly reduced workforce and depends heavily on a small number of key executives. Loss of these personnel could impair compliance, liquidity management, and strategic execution.
• Warranty and Legacy Obligations Risk: The company remains responsible for warranty servicing and other obligations related to legacy products, with potential cost uncertainties that could adversely affect financial condition and liquidity.
• Cybersecurity Risk: Limited workforce and reliance on information systems expose ClearOne to cybersecurity risks, including unauthorized access and ransomware attacks, which could result in regulatory scrutiny, legal claims, and operational disruption.
• Market and Economic Risk: Global economic conditions, capital market volatility, and geopolitical conflicts may adversely affect ClearOne's ability to obtain financing or complete strategic transactions.
• Ownership Concentration Risk: The largest stockholder holds majority voting power and consent rights, potentially influencing corporate decisions and limiting other stockholders' influence.

• ClearOne, Inc. is a Delaware corporation that was previously engaged in designing, developing, and marketing professional audio conferencing, microphone, and video collaboration solutions [S1].
• In October 2025, ClearOne completed the sale of certain intellectual property, product inventory, and non-exclusive rights to customer data to Biamp Systems, LLC for $3.0 million in cash consideration [S1].
• Following the October 2025 asset sale, ClearOne no longer manufactures or sells products and maintains a limited inventory to service warranty claims [S1].
• Current activities include fulfilling warranty and technical support obligations on legacy products, managing and liquidating remaining assets, evaluating potential strategic transactions, collecting accounts receivable, satisfying liabilities, and maintaining public company compliance [S1].
• These continuing activities are transitional and are not expected to generate material revenue [S1].
• ClearOne is actively evaluating strategic alternatives to enhance stockholder value, including special transactions, investments, acquisitions, additional asset sales, or other actions [S1].
• The company completed a 15-for-1 reverse stock split in June 2025, adjusting all share and per-share amounts accordingly [S1].
• As of June 30, 2026, ClearOne had $75,000 in cash and cash equivalents, current assets of $976,000, current liabilities of $929,000, a current ratio of 1.05, and a cash ratio of 0.08 [S2].
• For the quarter ended June 30, 2026, ClearOne reported a net loss of $914,000 and basic and diluted EPS of -$0.34 [S2].
• The company has incurred significant losses and negative cash flows, and there is substantial doubt about its ability to continue as a going concern [S1].
• ClearOne's continuing activities are not expected to generate sufficient revenue to fund ongoing operating costs; additional financing or strategic transactions are required to sustain operations [S1, S2].
• ClearOne is at risk of delisting from the Nasdaq Capital Market due to non-compliance with listing standards, including minimum stockholders' equity requirements [S1, S2].
• The company completed reincorporation from Delaware to Nevada in April 2026, which may affect stockholder rights and governance [S2].
• On July 1, 2026, ClearOne entered into a merger agreement to acquire Cortigent, Inc., a subsidiary of Vivani Medical, Inc., with Cortigent becoming a wholly-owned subsidiary post-merger [S2, N1].
• The merger consideration includes issuing 12,500,000 shares of ClearOne common stock to Vivani, representing approximately 82% of pro forma common stock before financing [S2].
• ClearOne plans a concurrent financing to raise $10 million to $15 million through a registration statement on Form S-1, structured as units of common stock and warrants [S2].
• Post-merger, Vivani will hold majority voting power and designate key executive officers and most board members [S2].
• The merger and financing are subject to multiple conditions including stockholder approvals, Nasdaq initial listing approval, and registration statement effectiveness [S2].
• Failure to complete the merger or financing could result in substantial costs without an operating business and continued substantial doubt about going concern status [S2].
• ClearOne entered into a loan agreement with First Finance Ltd. in June 2026 for up to $1 million with an 11% interest rate and maturity in December 2026, to be used for general working capital [S12].
• The company has advisor agreements with several entities including First Finance Ltd. for advisory services compensated with common stock issuances [S14].
• ClearOne operates with a significantly reduced workforce and is highly dependent on a small number of executive officers and key personnel to manage compliance, warranty servicing, asset management, and strategic evaluations [S1, S11].
• The largest stockholder, First Finance Ltd., beneficially owned approximately 61.3% of outstanding common stock as of March 2026 and has significant influence over corporate matters including voting and consent rights [S1, S11].
• ClearOne maintains information technology systems supporting financial reporting, compliance, warranty servicing, and administrative functions, with cybersecurity risk management overseen by the Audit Committee [S10].
• The company faces risks from cybersecurity incidents due to limited workforce and potential vulnerabilities, which could result in regulatory scrutiny, legal claims, reputational harm, and operational disruption [S10].
• Global economic conditions, capital market volatility, and geopolitical conflicts may adversely affect ClearOne's ability to obtain financing or complete strategic transactions [S9].
• Following the asset sale, ClearOne remains responsible for warranty and other obligations related to products sold prior to the sale, with potential cost uncertainties [S4].
• The company has experienced revenue declines and wider losses in recent quarters, with stock price declines reported in multiple news articles [N4, N8].
• ClearOne's stock has been highlighted in analyst blogs and stock reports alongside other companies, indicating some market attention [N2, N3, N6, N7].
• The merger with Cortigent creates a Nasdaq-listed Cortigent Holdings entity, representing a significant strategic transaction for ClearOne [N1].